CVS Health Operating Segments — D&A decreased by 2.8% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.4%, from $1.15B to $1.12B. Over 4 years (FY 2021 to FY 2025), Operating Segments — D&A shows relatively stable performance with a 0.7% CAGR.
High levels relative to revenue suggest a capital-intensive business model, while sudden changes may indicate shifts in asset investment strategies.
This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within a...
Standard non-cash expense reported in segment-level notes or cash flow statements.
cvs_segment_operating_segments_depreciation_depletion_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.14B | $1.13B | $1.09B | $1.05B | $1.08B | $1.05B | $1.04B | $1.00B | $1.10B | $1.13B | $1.13B | $1.14B | $1.15B | $1.16B | $1.15B | $1.15B | $1.17B | $1.13B | $1.15B | $1.12B |
| QoQ Change | — | -0.3% | -4.0% | -3.7% | +3.1% | -3.0% | -0.7% | -4.0% | +10.3% | +2.1% | +0.6% | +0.4% | +1.1% | +0.9% | -1.2% | +0.6% | +1.5% | -3.2% | +1.1% | -2.8% |
| YoY Change | — | — | — | — | -4.8% | -7.4% | -4.2% | -4.6% | +2.0% | +7.3% | +8.7% | +13.7% | +4.3% | +3.0% | +1.1% | +1.4% | +1.7% | -2.3% | +0.0% | -3.4% |